Vaibhav Kapuria

1.1k total citations
21 papers, 899 citations indexed

About

Vaibhav Kapuria is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Vaibhav Kapuria has authored 21 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Hematology. Recurrent topics in Vaibhav Kapuria's work include Glycosylation and Glycoproteins Research (6 papers), Ubiquitin and proteasome pathways (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Vaibhav Kapuria is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Ubiquitin and proteasome pathways (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Vaibhav Kapuria collaborates with scholars based in United States, Switzerland and India. Vaibhav Kapuria's co-authors include Nicholas J. Donato, Moshe Talpaz, Luke F. Peterson, William G. Bornmann, Dexing Fang, Winship Herr, Geoffrey Bartholomeusz, Jiaoyang Jiang, Suzanne Walker and Michael B. Lazarus and has published in prestigious journals such as Science, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Vaibhav Kapuria

21 papers receiving 887 citations

Peers

Countries citing papers authored by Vaibhav Kapuria

Since Specialization

Citations

This map shows the geographic impact of Vaibhav Kapuria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaibhav Kapuria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaibhav Kapuria more than expected).

Fields of papers citing papers by Vaibhav Kapuria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaibhav Kapuria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaibhav Kapuria. The network helps show where Vaibhav Kapuria may publish in the future.

Co-authorship network of co-authors of Vaibhav Kapuria

This figure shows the co-authorship network connecting the top 25 collaborators of Vaibhav Kapuria. A scholar is included among the top collaborators of Vaibhav Kapuria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaibhav Kapuria. Vaibhav Kapuria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HCF-1 as a key modulator of OGT function and O-GlcNAcylation in the liver 2025 ·Scientific Reports ·Vaibhav Kapuria, (unknown), Winship Herr, Shilpi Minocha	1
2	The conserved threonine-rich region of the HCF-1PRO repeat activates promiscuous OGT:UDP-GlcNAc glycosylation and proteolysis activities 2018 ·Journal of Biological Chemistry ·Vaibhav Kapuria, Ute F. Röhrig, Patrice Waridel, (unknown), Vladimir S. Borodkin, Daan M. F. van Aalten, Vincent Zoete, Winship Herr	11
3	Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats 2017 ·Open Biology ·Karim Rafie, Olawale G. Raimi, Andrew T. Ferenbach, Vladimir S. Borodkin, Vaibhav Kapuria, Daan M. F. van Aalten	44
4	Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes 2016 ·Genes & Development ·Vaibhav Kapuria, Ute F. Röhrig, (unknown), Vladimir S. Borodkin, Daan M. F. van Aalten, Vincent Zoete, Winship Herr	19
5	Distinct OGT-Binding Sites Promote HCF-1 Cleavage 2015 ·PLoS ONE ·(unknown), Patrice Waridel, Vaibhav Kapuria, Vincent Zoete, Winship Herr	20
6	Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I) 2014 ·Bioorganic & Medicinal Chemistry ·Zhenghong Peng, David S. Maxwell, Duoli Sun, (unknown), (unknown), Ashutosh Pal, (unknown), Dongmei Han, Liwei Gao, Shimei Wang, Alexander Levitzki, Vaibhav Kapuria, Moshe Talpaz, Matthew A. Young, Hollis D. Showalter, Nicholas J. Donato, William G. Bornmann	12
7	HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase 2013 ·Science ·Michael B. Lazarus, Jiaoyang Jiang, Vaibhav Kapuria, (unknown), John Janetzko, Wesley F. Zandberg, David J. Vocadlo, Winship Herr, Suzanne Walker	155
8	A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination 2011 ·Cellular Signalling ·Vaibhav Kapuria, Alexander Levitzki, William G. Bornmann, David S. Maxwell, Waldemar Priebe, Roderick J. Sorenson, Hollis D. Showalter, Moshe Talpaz, Nicholas J. Donato	39
9	Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activity 2011 ·Biochemical Pharmacology ·Vaibhav Kapuria, Luke F. Peterson, Hollis D. Showalter, Paul D. Kirchhoff, Moshe Talpaz, Nicholas J. Donato	38
10	Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis 2011 ·Blood ·Hanshi Sun, Vaibhav Kapuria, Luke F. Peterson, Dexing Fang, William G. Bornmann, Geoffrey Bartholomeusz, Moshe Talpaz, Nicholas J. Donato	99
11	A Small Molecule Deubiquitinase Inhibitor Increases Localization of Inducible Nitric Oxide Synthase to the Macrophage Phagosome and Enhances Bacterial Killing 2011 ·Infection and Immunity ·Kristin M. Burkholder, Jeffrey W. Perry, Christiane E. Wobus, Nicholas J. Donato, Hollis D. Showalter, Vaibhav Kapuria, Mary O’Riordan	13
12	Deubiquitinase Usp9X Regulates Cell Survival and Metabolic Signal Transduction in Multiple Myeloma Cells 2011 ·Blood ·Luke F. Peterson, Hanshi Sun, Vaibhav Kapuria, Malathi Kandarpa, Moshe Talpaz, Andrzej Jakubowiak, Nicholas J. Donato	1
13	Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis 2010 ·Cancer Research ·Vaibhav Kapuria, Luke F. Peterson, Dexing Fang, William G. Bornmann, Moshe Talpaz, Nicholas J. Donato	317
14	Inhibition of Usp9x Deubiquitinase Activity by WP1130 Reduces Mcl-1 Levels and Induces Apoptosis In Cells From Patients with Plasma Cell Dyscrasia and Drug-Refractory Multiple Myeloma 2010 ·Blood ·Hanshi Sun, Vaibhav Kapuria, Luke F. Peterson, Diane Giannola, Malathi Kandarpa, Moshe Talpaz, Andrzej Jakubowiak, Nicholas J. Donato	4
15	WP1130 Inhibits Signaling through BCR-ABL Ubiquitination and Cytoplasmic to Aggresome Trafficking to Induce Apoptosis of CML Cells. 2009 ·Blood ·Nicholas J. Donato, Hanshi Sun, Vaibhav Kapuria, Luke F. Peterson, Geoffrey Bartholomeusz, William G. Bornmann, Moshe Talpaz	1
16	Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells 2007 ·Blood ·Geoffrey Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev Estrov, Waldemar Priebe, Ji Yuan Wu, Nicholas J. Donato	81
17	A Novel Small-Molecule Approach To Inhibit Jak2 Tyrosine Kinase Signaling. 2007 ·Blood ·Vaibhav Kapuria, Geoffrey Bartholomeusz, Lingyuan Kong, William G. Bornmann, Zhenghong Peng, Ashutosh Pal, David S. Maxwell, Moshe Talpaz, Nicholas J. Donato	2
18	Degrasyn-Induced Trafficking of BCR-ABL as a Novel Mechanism of Kinase Inactivation. 2007 ·Blood ·Nicholas J. Donato, Vaibhav Kapuria, Hanshi Sun, David S. Maxwell, Geoffrey Bartholomeusz, William G. Bornmann, Zhenghong Peng, Ashutosh Pal, Moshe Talpaz	2
19	Association of −308 TNF‐α promoter polymorphism with type 1 diabetes in North Indians 2006 ·International Journal of Immunogenetics ·Satya N. Das, (unknown), Vaibhav Kapuria	21
20	Antitumor Activity and Mechanism of Action of a Novel Stat3 Inhibitor, WP1066, Against Human B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma. 2005 ·Blood ·Lingyuan Kong, Vaibhav Kapuria, Geoffrey Bartholomeusz, Moshe Talpaz, Waldemar Priebe, Nicholas J. Donato	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact